Lipella Pharms Inc (LIPO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,068 | -2,598 | -2,234 | -1,520 | -738 |
| Accounts receivable | 30 | -114 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -235 | 338 | 306 | 9 | 10 |
| Other Working Capital | -224 | 10 | -118 | -211 | -198 |
| Other Operating Activity | 420 | 534 | 447 | 443 | 227 |
| Operating Cash Flow | $-1,078 | $-1,831 | $-1,600 | $-1,279 | $-699 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 301 | 301 | 301 | -300 |
| Other Investing Activity | 0 | 1 | 0 | 0 | 0 |
| Investing Cash Flow | $N/A | $301 | $301 | $301 | $-300 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 275 | N/A | N/A | N/A |
| Common Stock Issued | N/A | 4,964 | N/A | N/A | N/A |
| Other Financing Activity | -25 | 1 | 0 | 0 | 0 |
| Financing Cash Flow | $-25 | $5,239 | $N/A | $N/A | $N/A |
| Beginning Cash Position | 5,122 | 1,414 | 1,414 | 1,414 | 1,414 |
| End Cash Position | 4,019 | 5,122 | 115 | 435 | 414 |
| Net Cash Flow | $-1,103 | $3,708 | $-1,299 | $-979 | $-999 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,078 | -1,831 | -1,600 | -1,279 | -699 |
| Free Cash Flow | -1,078 | -1,831 | -1,600 | -1,279 | -699 |